Sunday, April 3, 2022

Advocacy group launches campaign to hold newly elected politicians accountable on drug price promises

An advocacy group is challenging newly elected and re-elected politicians to keep campaign promises to lower drug prices. A new ad launched this week features a video clip montage of winning senators and President-elect Joe Biden pledging to lower drug prices during their recent runs.

The digital and social effort from Patients for Affordable Drugs is actually the second step in its push to hold politicians accountable. The organization ran a seven-figure digital and TV campaign this summer and fall in New York City, Washington, D.C., and 15 states, encouraging voters to question candidates and ask for action on drug pricing. They then tracked candidates’ debates and political advertising to compile the video ad running now.

RELATED: As Trump, Biden face off, could drug pricing reforms await? Experts are split, but pharma is watching closely

Free Webinar

Hindsight is so 2020 – Getting Ahead of CNS Trial Enrollment in a Rapidly Changing Clinical Landscape

The past six months have highlighted both existing and unexpected enrollment challenges, as sponsors, CROs, and sites have been pressed to evolve their recruitment strategies. Join us as Rho experts discuss their approach to adapting CNS trial enrollment to a rapidly changing clinical landscape. Register now.

“All over the country candidates from both parties ran on a promise to lower drug prices,” David Mitchell, founder of Patients for Affordable Drugs, said. “Even in the midst of an election that was fraught with so many issues, drug pricing was one thing that candidates used everywhere. Folks ran on it, people voted on it and it’s time now for them to follow through.”

The effort, which includes patients’ letters and phone calls to the winning politicians, will run through the rest of the year and kick into its next phase after the presidential inauguration and Congress convenes in January.

The goal of the campaign is “to make sure that drug pricing is on the agenda, that politicians who said they were going to do something about it actually follow through, and then we’ll get more specific as we find out how legislative proposals are structured,” Mitchell said.

RELATED: Merck, Lilly and Amgen win again in lawsuit over drug prices in TV ads. Will it stick?

With a new administration, Mitchell sees two reasons to be hopeful that action will be taken. One is that drug pricing is bipartisan and both Democrat and Republican congress members may look to reap the benefits with constituents by taking it up. The other is that drug pricing legislation could save the administration money when federal budgets are tightening.

“People agree—Democrats, Republicans and Independents—that something should be done to lower drug prices,” he said. “President-elect Biden says his number one priority is to try and unify the county, and I can’t think of a more unifying issue than lowering drug prices.”

Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...